| Literature DB >> 12175542 |
Akira Murakami1, Yoshimasa Nakamura, Koichi Koshimizu, Daisuke Takahashi, Kazuhiro Matsumoto, Kazuma Hagihara, Hisaji Taniguchi, Eisaku Nomura, Asao Hosoda, Takuo Tsuno, Yuko Maruta, Ha Won Kim, Kyuichi Kawabata, Hajime Ohigashi.
Abstract
In our previous study, FA15 (2-methyl-1-butyl ferulic acid) was chemically synthesized as a novel ferulic acid (FA) analog, and found to notably suppress phorbol ester-induced Epstein-Barr virus activation and superoxide anion generation in vitro. In this report, we demonstrated that FA15, in contrast to FA, markedly suppressed the combined lipopolysaccharide and interferon-gamma-induced protein expressions of inducible nitric oxide synthase and cyclooxygenase-2, and also inhibited the release of tumor necrosis factor-alpha accompanied by suppression of I-kappa B degradation in RAW264.7, a murine macrophage cell line. In ICR mouse skin, topical application of FA15 significantly attenuated phorbol ester-triggered hydrogen peroxide production and edema formation as well as papilloma development while that of FA did not. Our results suggest that FA15, derived from natural sources, is a novel chemopreventive agent, both structurally and functionally.Entities:
Mesh:
Substances:
Year: 2002 PMID: 12175542 DOI: 10.1016/s0304-3835(01)00858-8
Source DB: PubMed Journal: Cancer Lett ISSN: 0304-3835 Impact factor: 8.679